6XLO
Crystal structure of bRaf in complex with inhibitor
Summary for 6XLO
Entry DOI | 10.2210/pdb6xlo/pdb |
Descriptor | Serine/threonine-protein kinase B-raf, 3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide, IODIDE ION, ... (4 entities in total) |
Functional Keywords | kinase, inhibitor, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 66703.11 |
Authors | Yin, J.,Eigenbrot, C.,Wang, W. (deposition date: 2020-06-28, release date: 2021-05-26, Last modification date: 2023-10-18) |
Primary citation | Huestis, M.P.,Dela Cruz, D.,DiPasquale, A.G.,Durk, M.R.,Eigenbrot, C.,Gibbons, P.,Gobbi, A.,Hunsaker, T.L.,La, H.,Leung, D.H.,Liu, W.,Malek, S.,Merchant, M.,Moffat, J.G.,Muli, C.S.,Orr, C.J.,Parr, B.T.,Shanahan, F.,Sneeringer, C.J.,Wang, W.,Yen, I.,Yin, J.,Siu, M.,Rudolph, J. Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3 H )-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor. J.Med.Chem., 64:3940-3955, 2021 Cited by PubMed: 33780623DOI: 10.1021/acs.jmedchem.0c02085 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.493 Å) |
Structure validation
Download full validation report